ロード中...
Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy
SIMPLE SUMMARY: Cancer therapy has evolved over the years, immunotherapy being the most used for untreatable malignant tumors. Immune checkpoint inhibitors decrease the ability of tumor cells to escape the immune system. Although immune checkpoint inhibitors have a significant impact in the treatmen...
保存先:
| 出版年: | Biology (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8235766/ https://ncbi.nlm.nih.gov/pubmed/34203101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology10060561 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|